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Abstract A sensitive and specific radioimmunoassay for orexin
A was developed. Orexin A immunoreactivity was found to be
confined to the central nervous system (CNS) with the highest
concentrations in the hypothalamus, inferior and superior
colliculi and brainstem. Within the hypothalamus, the highest
levels were found in the lateral and posterior hypothalamus.
These regions had a greater orexin A content in females
compared to males. The orexin A content of hypothalamic
regions did not change with fasting and no difference was noted
in hypothalami of rats fed a high fat diet. The hypothalamic
orexin A content was not different in obese Zucker rats
compared to lean controls. Thus, orexin A has a wide distribution
in the CNS, but appetite regulation may not be its main function.
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1. Introduction
The understanding of the central nervous system (CNS)
mechanisms that regulate the food intake and energy balance
has advanced beyond the early experiments that identi¢ed
regions of the hypothalamus as feeding (ventromedial hypo-
thalamus) and satiety (lateral hypothalamus) centres. Several
neuropeptides within the hypothalamus have been identi¢ed
that mediate feeding and satiety [1]. Recently, a family of
peptides (hypocretins/orexins) has been discovered that has
been implicated in the regulation of food intake and energy
balance [2,3]. Hypocretins were discovered through directional
tag PCR subtraction in search of brain homologues of the gut
peptide secretin [4]. Hypocretin mRNA encodes two proteins
named hypocretin-1 and hypocretin-2. In search of ligands for
orphan G protein-coupled receptors, two peptides, orexin A
and B, were discovered. These peptides were shown to in-
crease the food intake when injected into the lateral cerebral
ventricle of rats and were therefore named orexins [5]. Fur-
thermore, the orexin precursor (prepro-orexin) mRNA was
shown to be up-regulated in the hypothalamus of fasted rats
[5]. Shortly after the identi¢cation of hypocretins and orexins,
it was discovered that they represent the same family of pep-
tides with hypocretin-1 being the same as orexin A and hypo-
cretin-2 being the same as orexin B [6].
Prepro-orexin is a 130 amino acid precursor that is proc-
essed to orexin A, a carboxy-amidated 33 amino acid peptide
with two intra-chain disul¢de bonds, and orexin B, a 28 ami-
no acid carboxy-amidated linear peptide. Orexin immunoreac-
tive ¢bres have been detected in the lateral hypothalamus,
dorsomedial hypothalamus, posterior hypothalamus and peri-
fornicial hypothalamus [7]. Nerve terminals immunoreactive
for these peptides have been detected throughout the hypo-
thalamus (in particular the arcuate and paraventricular nu-
clei), the thalamus, cerebral cortex, the limbic system and
the brainstem (particularly areas that regulate the CNS mono-
aminergic system: the locus coeruleus and the raphe nucleus)
[7]. Two G protein-coupled receptors have been identi¢ed for
these peptides (OX1R and OX2R). Orexin A has a high af-
¢nity for both receptors, while orexin B has a 10-fold greater
a⁄nity for OX2R [5]. OX1R and OX2R have di¡erent distri-
butions within the brain. OX1R mRNA has been reported to
be most abundant in the ventromedial hypothalamus, but has
also been detected at high levels in the tenia tecta, the hippo-
campal formation, dorsal raphe and locus coeruleus [8].
OX2R mRNA is predominantly expressed in the paraventric-
ular hypothalamic nucleus, but has also been found at high
levels in subthalamic and thalamic nuclei, the cerebral cortex,
nucleus accumbens and anterior pretectal nucleus [8]. The
widespread distribution of the orexin family of peptides and
their receptors has suggested other roles for these peptides
beside the regulation of feeding. For example, these peptides
have been implicated in the regulation of pituitary LH release,
temperature, heart rate, locomotor activity, metabolic rate,
glucose homeostasis and gastric acid secretion [9^11].
The distribution of orexins has been investigated using sev-
eral techniques, but quanti¢cation of these peptides through-
out multiple speci¢c regions of the CNS has so far not been
carried out. In the present study, a highly sensitive and spe-
ci¢c radioimmunoassay (RIA) for orexin A was developed.
Using this assay, the content and distribution of immunoreac-
tive orexin A (orexin A-IR) in the CNS, hypothalamic regions
and peripheral tissues was quantitatively investigated in both
male and female animals. The e¡ect of fasting on the hypo-
thalamic orexin A content and the orexin A content in the
hypothalami of high fat diet (45% of calories)-fed animals and
hypothalami of lean Zucker (fa/+) rats and Zucker (fa/fa)
rats, with defective leptin action, was also investigated.
2. Materials and methods
2.1. Tissue preparation and peptide extraction
Adult male and female Wistar rats weighing 250^300 g (n = 4^7;
I.C.S.M., London, UK) were killed by decapitation and the brain,
spinal cord, pineal gland, pituitary gland, adrenal gland, gastrointes-
tinal tract, liver, testis, ovary, trachea, lung, heart, spleen and kidney
were rapidly dissected and removed. The brain was immediately dis-
sected into multiple regions including the hypothalamus. The hypo-
thalamus was dissected into four regions (anterior/preoptic, ventrome-
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dial, lateral and posterior, based on [12]) using ¢ne dissection under
magni¢cation. The spinal cord was subdivided into cervical, thoracic
and lumboscaral regions using conventional gross anatomical divi-
sions. Adult male Wistar rats were fasted for 48 h and then decapi-
tated with the tissues of various brain regions dissected and the hy-
pothalamus microdissected into four regions as above. Lean fa/+
(250^300 g, n = 11) and obese fa/fa (450^500 g, n = 12) adult male
Zucker rats (Charles River, Bicester, UK) were decapitated and their
hypothalami rapidly dissected and removed. A group of male Wistar
rats (250^300 g, n = 5) was given a high fat diet (45% of calories as
fat; D12451, Research Diets, New Brunswick, NJ, USA) ad libitum
for 2 weeks while a control group (n = 5) was given a low fat diet from
the same supplier (10% of calories as fat; D1245OB) for the same
period. At the end of 2 weeks, the animals were decapitated and their
hypothalami dissected. All tissues obtained were immediately frozen
in liquid nitrogen and stored at 370‡C. The tissues were then ex-
tracted by boiling in 0.5 M acetic acid and stored at 320‡C prior
to assaying.
2.2. RIA
Antisera for orexin A were raised in New Zealand white rabbits
initially inoculated with 100 Wg of peptide, conjugated to bovine se-
rum albumin (BSA) by carbodiimide, mixed with an equal volume of
complete Freund’s adjuvant, followed by regular booster injections.
Synthetic orexin A was obtained from Peninsula laboratories (Mersey-
side, UK).
Orexin A antiserum showed full cross-reactivity with the synthetic
peptide. The peptide used in the assays was iodinated using the io-
dogen method. The RIA was set up as previously described [13]. The
¢nal antibody dilution was 1:100 000. Orexin A label was used at 30
Bq/tube. The assay was performed in 0.06 M phosphate bu¡er (pH
7.2) containing 0.3% BSA and 0.02% Tween 20. After 3 days incuba-
tion at 4‡C, antibody-bound and free fractions were separated by
charcoal adsorption of the free fraction. No signi¢cant cross-reactivity
was observed with orexin B or members of the secretin-glucagon
family of peptides. Inter- and intra-assay variation was established
to be less than 10%. The assay could detect changes of 0.2 fmol
between adjacent tubes.
2.3. Chromatography
Fractionation of orexin A from extracts of Wistar rat hypothala-
mus, thalamus, cerebellum and cerebral cortex (n = 3 per tissue) was
carried out using Sephadex G-50 Super¢ne (Pharmacia, Uppsala,
Sweden) on a 0.9U60 cm column and fast protein liquid chromatog-
raphy (FPLC) using a high resolution reverse-phase (Pep RPC HR 5/
5) C-18 column (Pharmacia, Uppsala, Sweden).
The Sephadex G-50 column was eluted at a £ow rate of 3.2 ml/h at
4‡C in 0.06 M phosphate bu¡er containing 0.2 M NaCl and 0.3%
BSA and 1 ml fractions were collected. To determine the relative
retention coe⁄cient of orexin A, dextran blue (30 mg/ml), horse heart
cytochrome c (30 mg/ml) and [125I]Na (Amersham International,
Buckinghamshire, UK) were added to each sample extract (n = 3 per
tissue type), which was loaded as a volume of 0.5 ml. RIA was used to
observe the elution pro¢le of orexin A from the tissue extracts and a
standard of the pure synthetic peptide.
Neat tissue extracts were centrifuged and the supernatants ¢ltered
through 0.2 Wm hydrophilic membranes (Sartorius AG, Goettingen,
Germany). Tissue extracts and synthetic peptide were independently
loaded on to the FPLC column (0.5 ml) and eluted with a 15^50%
gradient of acetonitrile (ACN)/0.1% TFA over 60 min at a £ow rate
of 1 ml/min per fraction. 100 Wl of each of the fractions collected was
analysed by RIA.
2.4. Data analysis
All results are presented as mean þ S.E.M. The peptide content for
brain regions and whole hypothalami is expressed as pmol/g wet
weight of tissue. For discrete hypothalamic regions, data are presented
as pmol/mg protein. The value of the relative elution coe⁄cient (Kav)
was calculated for each immunoreactive peak on G-50 column chro-
matography according to a modi¢cation [14] of the equation proposed
by Laurent and Killander [15]. For statistical analysis, comparisons
between microdissected hypothalamic regions were carried out by
analysis of variance (ANOVA). If the ANOVA was found to be sig-
ni¢cant (P6 0.05), then, further analysis was carried out using Fish-
er’s least squares di¡erences (LSD). The unpaired t-test was used for
all other statistical comparisons.
Table 1
Orexin A content (mean þ S.E.M., pmol/g tissue) in brain regions of fed and 48 h-fasted male Wistar rats and spinal cord regions (n = 4^7)
Brain/spinal cord region Orexin A content þ S.E.M. (pmol/g wet weight)
Fed 48 h-fasted
Olfactory bulbs 2.4 þ 0.3 2.5 þ 0.3
Olfactory tubercles 7.3 þ 0.6 8.0 þ 0.8
Thalamus 12.5 þ 0.7 9.8 þ 1.3
Cingulate cortex 4.8 þ 0.9 4.6 þ 0.5
Frontal cortex 2.5 þ 0.3 2.7 þ 0.4
Parietal cortex 3.4 þ 0.5 5.0 þ 0.6
Occipital cortex 4.5 þ 0.4 3.8 þ 0.8
Temporal cortex 2.7 þ 0.2 3.3 þ 0.6
Amygdala 5.8 þ 0.5 8.1 þ 1.8
Septal nuclei 14.2 þ 1.7 17.2 þ 1.1*
Striatum 4.5 þ 0.4 3.8 þ 0.8
Hippocampus 1.9 þ 0.2 2.1 þ 0.2
Pons 18.5 þ 3.1 14.3 þ 3.1
Medulla 14.3 þ 1.3 16.3 þ 2.2
Midbrain 12.8 þ 1.4 16.2 þ 0.9
Cerebellum 0.7 þ 0.2 1.2 þ 0.3
Superior colliculus 23.1 þ 1.8 22.0 þ 2.0
Inferior colliculus 20.4 þ 2.8 24.8 þ 0.3
Hypothalamus (whole) 19.4 þ 1.6 20.1 þ 2.7
Lateral hypothalamus (fmol/Wg protein) 2.0 þ 0.3 2.1 þ 0.2
Posterior hypothalamus (fmol/Wg protein) 1.2 þ 0.2 1.1 þ 0.03
Ventromedial hypothalamus (fmol/Wg protein) 2.1 þ 0.3 2.3 þ 0.2
Anterior hypothalamus (fmol/Wg protein) 1.5 þ 0.1 1.6 þ 0.2
Cervical spinal cord 3.7 þ 0.8
Thoracic spinal cord 1.3 þ 0.3
Lumbo-sacral spinal cord 2.3 þ 0.5
Septal nuclei is the only region showing a signi¢cant di¡erence between fed and fasted (P6 0.05). Spinal cord: P6 0.05 by ANOVA, cervical
versus thoracic P6 0.05, cervical versus lumbosacral, P6 0.05.
*P6 0.05
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3. Results
3.1. Orexin A-IR distribution and content
No orexin A was detected in peripheral tissues or in the
pineal and pituitary glands. Within the CNS, orexin A-IR
was detected in all regions studied, but its content was highest
in the hypothalamus, superior and inferior colliculi and brain-
stem (Table 1). In males, di¡erent hypothalamic regions (Ta-
ble 2) showed signi¢cant di¡erences (ANOVA P6 0.05, later-
al versus posterior P6 0.05 by LSD, posterior versus
ventromedial P6 0.05 by LSD). In females (Table 2), hypo-
thalamic regions showed a di¡erent pattern of variation (AN-
OVA P6 0.05, lateral versus anterior P6 0.01 by LSD, pos-
terior versus anterior P6 0.01 by LSD). Comparing the
hypothalamic regions of males and females, the lateral and
posterior hypothalamus of females had a greater immuno-
reactivity than males (P6 0.05 and P6 0.01, respectively, by
a t-test). In the spinal cord (Table 1), the orexin A immuno-
reactivity of the various regions studied were found to be
signi¢cantly di¡erent with the cervical spinal cord having
the highest immunoreactive peptide content (ANOVA
P6 0.05, cervical versus thoracic P6 0.05 by LSD, cervical
versus lumbosacral P6 0.05 by LSD).
3.2. G-50 column chromatography and FPLC
Sephadex G-50 chromatography showed the same elution
pro¢le and peaks for the di¡erent regions of the brain tested
(Fig. 1). These immunoreactive peaks co-eluted with the syn-
thetic orexin A, which had a Kav of approximately 0.49.
FPLC of synthetic orexin A gave a single major immunoreac-
tive peak eluting at 30% ACN. FPLC of tissue extracts
showed major peaks corresponding to the synthetic peptide.
Minor immunoreactive peaks, not detected by G-50 chroma-
tography and indicating fragments of a lesser hydrophobicity,
were observed with FPLC for the hypothalamus, brainstem
and cerebral cortex, but not for the cerebellum (Fig. 2).
3.3. Orexin A-IR content in fasted rats, high fat-fed rats and
Zucker rats
No signi¢cant di¡erence in orexin A-IR content was ob-
served for any brain or hypothalamic region (except for the
septal nuclei, P6 0.05) when 48 h-fasted animals were com-
pared to fed animals (Table 1). In the same tissue samples
from hypothalamic regions, we have noted signi¢cant di¡er-
ences (up to 8-fold) with fasting in the content of other hy-
Table 2
Orexin A content of hypothalamic regions (mean þ S.E.M., pmol/mg
protein) of male and female rats (n = 3^7 per region)
Hypothalamic region Orexin A content þ S.E.M.
(pmol/mg protein)
Male Female
Lateral 2.0 þ 0.3 3.1 þ 0.4*
Posterior 1.2 þ 0.2 3.2 þ 0.5***
Ventromedial 2.1 þ 0.3 2.3 þ 0.2
Anterior 1.5 þ 0.1 1.3 þ 0.2
Males: P6 0.05 by ANOVA, lateral versus posterior P6 0.05, pos-
terior versus ventromedial P6 0.05. Females: P6 0.05 by ANOVA,
lateral versus anterior P6 0.01, posterior versus anterior P6 0.01.
*P6 0.05.
***P6 0.001.
Fig. 1. Representative Sephadex G-50 column chromatography of rat. a: Hypothalamus, b: brainstem, c: cerebellum, d: cortex extracts.
Std = elution of standard, CC = horse heart cytochrome c.
FEBS 22477 16-8-99
S. Taheri et al./FEBS Letters 457 (1999) 157^161 159
pothalamic peptides, such as cocaine and amphetamine-re-
lated transcript (CART) (unpublished data), which inhibit
food intake. No signi¢cant di¡erence in the hypothalamic
orexin A-IR of high fat-fed animals was observed compared
to low fat-fed controls (25.0 þ 2.0 versus 21.3 þ 2.0) despite a
signi¢cantly greater average weight gain in the high fat-fed
group (104 g versus 84.9 g, P6 0.001). No signi¢cant di¡er-
ence in the orexin A-IR of hypothalami from lean (fa/+) and
obese Zucker (fa/fa) rats was observed (20.7 þ 1.8 pmol/g ver-
sus 19.0 þ 0.7 pmol/g).
4. Discussion
Our results demonstrate that orexin A-IR is restricted to the
CNS where it has a widespread distribution. The high con-
centrations observed within the superior and inferior colliculi
are suggestive of a role in vision and hearing while high con-
centrations within the brainstem are in agreement with possi-
ble regulation of the autonomic function [16]. Orexin A-IR
could be detected in the spinal cord (with the cervical cord
having the highest concentration), but at much smaller con-
centrations compared to the rest of the CNS. Recently, it has
been reported that orexin immunoreactive ¢bres originating
from the lateral hypothalamus may have an important neuro-
transmitter/neuromodulator function within the spinal cord,
particularly in the modulation of sensation and the autonomic
nervous system [16]. Within the hypothalamus, orexin A-IR
was found to be most abundant in the lateral and posterior
hypothalamus.
The sex di¡erences observed in the hypothalamic regions
suggest that orexin A levels may be in£uenced by sex steroids.
It has been demonstrated that LH secretion is stimulated by
intracerebroventricular orexin (A or B) in oestrogen-replaced
ovariectomised rats, but these peptides are inhibitory to LH
secretion in unprimed ovariectomised rats [17]. Therefore, sex
steroids not only in£uence orexin A actions, but also a¡ect the
orexin A peptide content.
The lateral hypothalamus is an important centre for regu-
lation of food intake with the neuropeptides melanin-concen-
trating hormone (MCH) and orexins being abundant there.
Both centrally administered MCH [1] and orexins [5,18,19]
have been reported to increase food intake, but the e¡ects
of orexin A on food intake are more consistent than orexin
B. Innervation of orexin and MCH neurons in the lateral
hypothalamus by NPY/AGRP neurons from the arcuate nu-
cleus has suggested that MCH and orexins may act down-
stream of NPY/AGRP [20]. Orexin immunoreactive ¢bres,
in turn, innervate NPY/AGRP neurons in the arcuate nucleus
and the existence of a feedback loop has been suggested [1].
Prepro-orexin mRNA is up-regulated in the hypothalamus of
fasted animals [5], but unlike a recent study of the orexin
content in the brain [21], no changes in the peptide in any
hypothalamic or brain region (except in the septal nuclei) has
been observed in the present study. The physiological signi¢-
cance of changes in the orexin A-IR content in the septal
nuclei with fasting is at present unclear. Unlike the orexigenic
peptides NPY and galanin, no changes in the hypothalamic
orexin A-IR content were observed in high fat-fed animals
compared to low fat-fed controls. Although the orexin A-IR
content of whole hypothalami was unchanged, it is possible
Fig. 2. Representative FPLC pro¢les of: a, hypothalamus; b, brainstem; c, cerebellum and d, cerebral cortex extracts. Solid line, orexin A con-
centration. Broken line, % ACN.
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that discrete hypothalamic regions may show di¡erences.
Chronic leptin treatment has been shown to decrease the con-
centration of orexin A in the lateral hypothalamus [22,23]. In
the present study, no change in hypothalamic orexin A-IR
content was observed in Zucker rats with a defective leptin
action, but discrete hypothalamic regions need to be examined
for regional changes of peptide mRNA and content. The in-
teraction of leptin with orexins is further complicated by the
¢nding that unlike the potently orexigenic peptide NPY, pre-
pro-orexin mRNA is lower in leptin de¢cient ob/ob and leptin
receptor de¢cient db/db mice compared to control animals
[24].
The widespread distribution of orexin immunoreactivity
and orexin receptors within the CNS suggests that orexins
are important in several CNS regulatory mechanisms. The
precise physiological importance and role of orexins in the
regulation of appetite (particularly its interaction with other
neuropeptides and leptin) remain to be determined.
References
[1] Kalra, S.P., Dube, M.G., Pu, S., Xu, B., Horvath, T.L. and
Kalra, P.S. (1999) Endocr. Rev. 20, 68^100.
[2] Schwartz, M.W. (1998) Nat. Med. 4, 385^386.
[3] Flier, J.S. and Maratos-Flier, E. (1998) Cell 92, 437^440.
[4] De Lecca, L., Kildu¡, T.S., Peyron, C., Gao, X.B., Foye, P.E.,
Danielson, P.E., Fukahara, C., Battenberg, E.L., Gautvik, K.M.
and Sutcli¡e, J.G. (1998) PNAS 95, 322^327.
[5] Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli,
R.M., Ranaka, H., Williams, S.C., Richardson, J.A., Kozlowski,
G.P., Wilson, S., Arch, J.R.S., Buckingham, R.E., Haynes, A.C.,
Carr, S.A., Annan, R.S., Mcnulty, D.E., Liu, W.S., Terret, J.A.,
Elsbourbagy, N.A., Bergsma, D.J. and Yanagisawa, M. (1998)
Cell 92, 573^585.
[6] Nisoli, E., Carruba, M.O., Valerio, A. and Borsani, G. (1998)
Nat. Med. 4, 645.
[7] Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisa-
wa, M. and Goto, K. (1999) Brain Res. 827, 243^260.
[8] Trivedi, P., Hong, Y., Douglas, J., MacNeil, L.H.T., Van der
Ploeg and Guan, X.-M. (1998) FEBS Lett. 438, pp. 71^75.
[9] Ida, T., Nakaharu, K., Katayama, T., Murakami, N. and Naka-
zato, M. (1999) Brain Res. 821, 526^529.
[10] Lubkin, M. and Stricker-Krongrad, A. (1998) Biochem. Biophys.
Res. Commun. 253, 241^245.
[11] Takahashi, N., Okumura, T., Yamad, H. and Kohgo, Y. (1999)
Biochem. Biophys. Res. Commun. 254, 623^627.
[12] Palkovits, M. and Brownstein, M.J. (1988) Maps and Guide to
Microdissection of the Rat Brain, Elsevier, London.
[13] Adrian, T.E. (1982) in: Radioimmunoassay of Gut Regulatory
Peptides (Bloom, S.R. and Long, R.G., Eds.), W.B. Saunders,
Philadelphia.
[14] Andrews, P. (1970) Methods Biochem. Anal. 18, 1^53.
[15] Laurent, T.C. and Killander, J.A. (1964) J. Chromatogr. 14, 317^
330.
[16] Van den Pol, A.N. (1999) J. Neurosci. 19, 3171^3182.
[17] Pu, S., Jain, M.R., Kalra, P.S. and Kalra, S.P. (1998) Regul.
Pept. 78, 133^136.
[18] Edwards, C.M., Abusnana, S., Sunter, D., Murphy, K.G., Gha-
tei, M.A. and Bloom, S.R. (1999) J. Endocrinol. 160, 7^12.
[19] Sweet, D.C., Levine, A.S., Bullington, C.J. and Kotz, C.M.
(1999) Brain Res. 821, 535^538.
[20] Broberger, C., De Lecca, L., Sutcli¡e, J.G. and Hokfelt, T.,
J. Comp. Neurol. 402, pp. 460^474.
[21] Mondal, M.S., Nakazato, M., Date, Y., Murakami, N., Yanagi-
saw, M. and Shigeru, M. (1999) Biochem. Biophys. Res. Com-
mun. 256, 495^499.
[22] Beck, B. and Richy, S. (1999) Biochem. Biophys. Res. Commun.
258, 119^122.
[23] Moriguchi, T., Sakurai, T., Nambu, T., Yanagisawa, M. and
Goto, K. (1999) Biochem. Biophys. Res. Commun. 264, 101^104.
[24] Yamamoto, Y., Ueta, Y., Date, Y., Nakazato, M., Hara, Y.,
Serino, R., Nomura, M., Shibuya, I., Matsukura, S. and Yama-
shita, H. (1999) Brain Res. Mol. Brain Res. 65, 14^22.
FEBS 22477 16-8-99
S. Taheri et al./FEBS Letters 457 (1999) 157^161 161
